Last10K.com

Advansource Biomaterials Corp (ASNB) SEC Filing 10-K Annual report for the fiscal year ending Monday, March 31, 2014

Advansource Biomaterials Corp

HISTORY TOOLS
CIK: 1011060 Ticker: ASNB

View differences made from one year to another to evaluate Advansource Biomaterials Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advansource Biomaterials Corp.

Continue

Assess how Advansource Biomaterials Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advansource Biomaterials Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ASNB
CIK: 1011060
Form Type: 10-K Annual Report
Accession Number: 0001011060-14-000021
Submitted to the SEC: Mon Jul 14 2014 2:57:29 PM EST
Accepted by the SEC: Mon Jul 14 2014
Period: Monday, March 31, 2014
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/asnb/0001011060-14-000021.htm